MZINT (I-123)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MZINT (I-123), covering 2010-10-06 to 2010-10-06. Get the full timeline:
Most recent: Clinical Trial Update: Assessment of the Biodistribution and Safety of 123-I MZINT in Healthy Subjects and Parkinson Disease Patients [Phase 1]